Illumina Inc (NAS:ILMN)
$ 146.17 -1.45 (-0.98%) Market Cap: 23.18 Bil Enterprise Value: 25.15 Bil PE Ratio: 0 PB Ratio: 10.87 GF Score: 80/100

Illumina Inc at JPMorgan Healthcare Conference (Virtual) and Q&A Session Transcript

Jan 11, 2021 / 07:00PM GMT
Release Date Price: $362.06 (-1.88%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Okay. Good afternoon. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this afternoon, Illumina. (Operator Instructions)

And with that, let me turn it over to Francis.

Francis A. deSouza
Illumina, Inc. - CEO, President & Director

Thank you, Tycho and the JPMorgan team for hosting us. And thank you, everyone, for joining us today. Our presentation today includes non-GAAP financial measures and forward-looking statements. Reconciliations to GAAP measures are included in our presentation. Please refer to our SEC filings for a full presentation of risks.

Going to Slide 3. The current pandemic has highlighted the critical role that genomics and Illumina will play in global health. In December 2019, Illumina worked with the Wuhan public health authorities to identify the cause of the COVID-19 outbreak. And in January 2020, the Shanghai Public Health Clinical Center used our instruments to sequence and publish the first

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot